retatrutide clinical trial information A new from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes Retatrutide Shows 28% Weight Loss

What Changed in 2026 In early 2026, the government announced plans to let about 14 peptides including BPC157 and TB500 be made again by licensed pharmacies with a doctors prescription

It does not activate GIPR

GLP-3RT is a multi receptor research peptide studied in controlled laboratory environments for its interaction with GLP-1, GIP, and glucagon receptor signaling pathways

Retatrutide vs Tirzepatide (Mounjaro): 28.7% vs 22.5% (2026 Data) Phase 3 trial comparison: Retatrutide 28.7% weight loss vs Tirzepatide 22.5%

Each supplement is slightly different, but these are a few ingredients that have come up: L-taurine (an amino acid) Prebiotics (fibre that feed good bacteria in your gut) Boron (a trace element) Berberine (a plant-based substance) Eriomin (lemon extract) Supresa (saffron extract) Morosil (blood orange extract) Green tea leaf extract (concentrated green tea) These can all impact the body, yes, but its a stretch to suggest that these would have the same effect as GLP-1 receptor agonist medications, says Dr Mir Ali, a bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center

Feeling sick (nausea)